Yavuz, S. Et Al. 2017. Meta-analysis of the effect of rituximab in the treatment of primary central nervous system lymphoma. 42nd European-Society-for-Medical-Oncology Congress (ESMO) , (Madrid, Spain).

Yavuz, S., Yildirim, M., Yazici, G., Kaya, V., & Paydas, S., (2017). Meta-analysis of the effect of rituximab in the treatment of primary central nervous system lymphoma . 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, Spain

Yavuz, S. Et Al. "Meta-analysis of the effect of rituximab in the treatment of primary central nervous system lymphoma," 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, Spain, 2017

Yavuz, S. Et Al. "Meta-analysis of the effect of rituximab in the treatment of primary central nervous system lymphoma." 42nd European-Society-for-Medical-Oncology Congress (ESMO) , Madrid, Spain, 2017

Yavuz, S. Et Al. (2017) . "Meta-analysis of the effect of rituximab in the treatment of primary central nervous system lymphoma." 42nd European-Society-for-Medical-Oncology Congress (ESMO) , Madrid, Spain.

@conferencepaper{conferencepaper, author={S. Yavuz Et Al. }, title={Meta-analysis of the effect of rituximab in the treatment of primary central nervous system lymphoma}, congress name={42nd European-Society-for-Medical-Oncology Congress (ESMO)}, city={Madrid}, country={Spain}, year={2017}}